echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Fosun Pharma’s holding subsidiary withdraws the registration application for cromolyn sodium granules

    Fosun Pharma’s holding subsidiary withdraws the registration application for cromolyn sodium granules

    • Last Update: 2021-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 24, Fosun Pharma issued an announcement stating that its holding subsidiary, Aohong Pharmaceutical, voluntarily applied to the State Food and Drug Administration for the withdrawal of the application for registration of marketing authorization for cromolyn sodium granules, and recently received the State Food and Drug Administration’s approval for the application.


    The new drug is a generic drug independently developed by the company and is intended to be mainly used for the treatment of atopic dermatitis caused by food allergies


    As of the date of this announcement, cromolyn sodium oral preparations that have been marketed globally mainly include Sanofi's INTAL®, etc.


    As of October 2021, the Group has invested approximately RMB 11.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.